Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.


Library CD
Volume 13, 2009 Archive
Six back issues from 2009 on one convenient archive.
Permanent storage and easy retrieval of IJPC articles and formulations.
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $200.00


(Select Format)
Instant PDF Download

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 13 No. 1 January/February 2009 Compounding for Pediatrics
Vol. 13 No. 2 March/April 2009 Sterile Compounding
Vol. 13 No. 3 May/June 2009 Pain Management
Vol. 13 No. 4 July/August 2009 Homone Replacement Therapy
Vol. 13 No. 5 September/October 2009 Veterinary Compounding
Vol. 13 No. 6 November/December 2009 Geriatric Compounding

Volume 13, 2009 Articles

Volume 13, 2009 Articles
Title (Click for Details) Vol/Issue Page
PreScription: A New Start: What Will 2009 Bring? Vol. 13 No. 1 4
Compounding for Pediatric Patients: Case Reports and Formulations Vol. 13 No. 1 6
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Vol. 13 No. 1 14
Compounding for Manufacturer Backorders and Discontinuations: "Oh, No! Not Again!" Vol. 13 No. 1 20
Compounding with Sucralfate for the Treatment of External Wounds Vol. 13 No. 1 25
Identifying the Criteria of a Valid Stability Study Vol. 13 No. 1 32
Summertime in an American Apothecary Garden Vol. 13 No. 1 38
Compounding for Cancer in Companion Animals Vol. 13 No. 1 42
Technology for the Compounding Pharmacy: Digital Pens--Tools or Toys? Vol. 13 No. 1 50
Quality Control Analytical Methods: Testing of Electrolytes Solutions Vol. 13 No. 1 53
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs Vol. 13 No. 1 56
Calculations Vol. 13 No. 1 63
Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets Vol. 13 No. 1 64
Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder Vol. 13 No. 1 65
Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel Vol. 13 No. 1 66
Dextromethorphan Hydrobromide 30-mg Troches Vol. 13 No. 1 67
Diaper Rash Cream with Miconazole Vol. 13 No. 1 68
Diphenhydramine Hydrochloride 25-mg Gelatin Troches Vol. 13 No. 1 69
Electrolyte Lollipop (Adult) Vol. 13 No. 1 70
Hydrogen Peroxide 1.5% and Sodium Fluoride 0.5-mg/mL Oral Rinse Vol. 13 No. 1 71
Peruvian Balsam, Zinc Stearate, Boric Acid, and Talcum Powder Vol. 13 No. 1 72
Tetracaine 0.025% Popsicles Vol. 13 No. 1 73
Testing of Estradiol in a Compounded Cream and a Stock Solution Vol. 13 No. 1 74
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Vol. 13 No. 1 78
The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials Vol. 13 No. 1 81
PostScription: The Compounding Pharmacy in Brazil: A Pharmacist's Perspective Vol. 13 No. 1 87
PreScription: Electronic Prescribing Vol. 13 No. 2 92
Compliance by Hospitals and Healthcare Facilities with the Revised United States Pharmacopeia Chapter <797> Vol. 13 No. 2 94
Tips for Cleanroom Construction and Renovation Vol. 13 No. 2 100
Contract Sterilization and Validation Companies Offer New Options for Sterile Compounded Preparations Vol. 13 No. 2 106
Treating Methicillin-Resistant Staphylococcus Aureus Infections with Compounded Vancomycin Preparations Vol. 13 No. 2 120
Compendial Activities Relating to Cold Chain Management Issues: Drug Products and Compounded Preparations Vol. 13 No. 2 128
Incorporating Web Communication to Maximize Staff Productivity in a Compounding Pharmacy Vol. 13 No. 2 138
Blogging for Business Vol. 13 No. 2 141
Quality-Control Analytical Methods: Compounding Slow-Release Pharmaceuticals Vol. 13 No. 2 144
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods Vol. 13 No. 2 146
Calculations Vol. 13 No. 2 151
Acidified Sodium Hypochlorite for Antisepsis and Disinfection Vol. 13 No. 2 152
Aprepitant 20-mg/mL Oral Liquid Vol. 13 No. 2 153
Chloroquine Phosphate 64.5-mg/mL Injection Vol. 13 No. 2 154
Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation Vol. 13 No. 2 155
Ionic Hydration Solution for Anti-Cancer Therapy Vol. 13 No. 2 156
Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection Vol. 13 No. 2 157
Nicotine Rectal Enema Vol. 13 No. 2 158
Thiothixene Hydrochloride 2-mg/mL Injection Vol. 13 No. 2 159
Tolterodine 2-mg/5-mL Oral Suspension Vol. 13 No. 2 160
Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection Vol. 13 No. 2 161
Drug Compatibility with a New Generation of VISIV Polyolefin Infusion Solution Containers Vol. 13 No. 2 162
Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions Vol. 13 No. 2 166
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule Vol. 13 No. 2 170
PostScription: Compounding in Argentina Vol. 13 No. 2 175
PreScription: A Good Name: Pharmacy Vol. 13 No. 3 180
Update on Managing Neuropathic Pain Vol. 13 No. 3 182
Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids Vol. 13 No. 3 192
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report Vol. 13 No. 3 196
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers Vol. 13 No. 3 214
Safe Use of Topical Local Anesthetic Medications for Pain Management Vol. 13 No. 3 218
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Vol. 13 No. 3 220
Compounded Medications in a Hospital Setting: Patient Counseling and Staff Education Vol. 13 No. 3 224
Quality-Control Analytical Methods: Pharmaceutical and Analytical Considerations of the Significance of pH Vol. 13 No. 3 230
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Vol. 13 No. 3 234
Calculations Vol. 13 No. 3 239
Analgesic Compound Lotion, Clear Vol. 13 No. 3 240
Hydromorphone Hydrochloride 10-mg/mL Oral Drops Vol. 13 No. 3 241
Lidocaine 2% Popsicle Vol. 13 No. 3 242
Morphine Sulfate 10-mg/mL Oral Solution Vol. 13 No. 3 243
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel Vol. 13 No. 3 244
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel Vol. 13 No. 3 245
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules Vol. 13 No. 3 246
Oxycodone Hydrochloride 20-mg Suppository Vol. 13 No. 3 247
Promethazine 20-mg and Acetaminophen 325-mg Suppositories Vol. 13 No. 3 248
Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules Vol. 13 No. 3 249
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding Vol. 13 No. 3 250
Stability of Pergolide Mesylate Oral Liquid at Room Temperature Vol. 13 No. 3 254
Formulation Optimization Study for an Immediate-Release Tablet Vol. 13 No. 3 259
PostScription: Compounding in Israel Vol. 13 No. 3 262
PreScription: Trust Vol. 13 No. 4 268
The Physiologic Role and Use of Estriol Vol. 13 No. 4 270
Hormone Treatment Options for Males: What to Do for Men with Low Testosterone Vol. 13 No. 4 276
Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation Vol. 13 No. 4 280
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Vol. 13 No. 4 290
Compounding Naltrexone for the Treatment of Autism Vol. 13 No. 4 296
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting Vol. 13 No. 4 300
Optimizing Your Website: Search Engine Optimization, Pay Per Click, Email Marketing Vol. 13 No. 4 311
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Vol. 13 No. 4 314
Quality-Control Analytical Methods: Quality Control, Quality Assurance, and Quality Improvement--What is the Difference and Why Should Compounding Pharmacies Care? Vol. 13 No. 4 318
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) Vol. 13 No. 4 322
Calculations Vol. 13 No. 4 330
Alcohol-based Carbomer Gel Vol. 13 No. 4 332
Benzoyl Peroxide 10% Gel Vol. 13 No. 4 333
Clindamycin 100-mg Vaginal Suppositories Vol. 13 No. 4 334
Dexamethasone and Furosemide Injection Vol. 13 No. 4 335
Instant Voice Vol. 13 No. 4 336
Moxifloxacin 20-mg/mL Oral Liquid Vol. 13 No. 4 337
Mupirocin 1% (20-mg) Vaginal Suppository Vol. 13 No. 4 338
Riley Butt Cream Vol. 13 No. 4 339
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil Vol. 13 No. 4 340
Trolamine Oleate Otic Solution Vol. 13 No. 4 341
Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison Vol. 13 No. 4 342
Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia Vol. 13 No. 4 345
PostScription: Compounding Pharmacy in Puerto Rico Vol. 13 No. 4 350
PreScription: Veterinary Pharmacy Vol. 13 No. 5 356
Transdermal Dosing Considerations for Veterinarians Vol. 13 No. 5 358
Little Thief: The Domestic Ferret Vol. 13 No. 5 362
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Vol. 13 No. 5 367
A Review of Stomatitis and Treatment in Cats Vol. 13 No. 5 372
Azithromycin in the Treatment of Pneumonic Foals Vol. 13 No. 5 382
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Vol. 13 No. 5 386
Recommended Tips for Treating Veterinary Patients Vol. 13 No. 5 390
Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing Vol. 13 No. 5 392
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Vol. 13 No. 5 400
An Abridged History of Aspirin Vol. 13 No. 5 404
Marketing Veterinarians Vol. 13 No. 5 410
Quality-Control Analytical Methods: Designing a Quality-Control Potency Testing Program for a Compounding Pharmacy Vol. 13 No. 5 412
Calculations Vol. 13 No. 5 419
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing Vol. 13 No. 5 420
Aceclofenac 1.5% Pluronic Lecithin Organogel Vol. 13 No. 5 428
Amlodipine Besylate 1 mg/mL Veterinary Suspension Vol. 13 No. 5 429
Cooling Ointment Vol. 13 No. 5 430
Emanuel Butt Paste Vol. 13 No. 5 431
Ferric Pyrophosphate 50-mg/mL Solution for Iontophoresis Vol. 13 No. 5 432
Lidocaine 10% Oral Pluronic Lecithin Organogel Vol. 13 No. 5 433
Mechlorethamine Hydrochloride 0.02% Topical Vol. 13 No. 5 434
Myristyl Nicotinate 5% Topical Gel Vol. 13 No. 5 435
Nitroglycerin 4-mg Suppository Vol. 13 No. 5 436
Zonisamide 10-mg/mL Oral Suspension Vol. 13 No. 5 437
Chemical Stability of Scopolamine Hydrobromide Nasal Solution Vol. 13 No. 5 438
Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study Vol. 13 No. 5 440
Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms Vol. 13 No. 5 445
PostScription: Setting up a National System of Compounding Pharmacies: An Introduction Vol. 13 No. 5 447
PreScription: Geriatric Compounding: An Opportunity for Pharmacists Vol. 13 No. 6 492
Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male Vol. 13 No. 6 494
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Vol. 13 No. 6 498
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Vol. 13 No. 6 506
Urinary Deoxypyridinoline Level Reveals Bone Resorption, Predicts Fracture Risk, and Enhances the Results of Dual Energy X-Ray Absorptiometry Vol. 13 No. 6 516
An Overview of United States Pharmacopeia Chapter <795> and American Society of Health-System Pharmacists Guidelines for Nonsterile Compounding Vol. 13 No. 6 525
Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust Vol. 13 No. 6 532
Marketing the Geriatric Patient Vol. 13 No. 6 538
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops Vol. 13 No. 6 540
Calculations Vol. 13 No. 6 545
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures Vol. 13 No. 6 546
Cidofovir 0.2-mg/mL Intravitreous Injection Vol. 13 No. 6 554
Fluconazole 2% Topical Microemulsion Vol. 13 No. 6 555
Gentian Violet Vaginal Suppositories Vol. 13 No. 6 556
Ichthammol 10% Otic Solution Vol. 13 No. 6 557
Lubow's Solution Vol. 13 No. 6 558
Miconazole 1% Ophthalmic Solution, Veterinary Vol. 13 No. 6 559
Topiramate 6-mg/mL Oral Suspension Vol. 13 No. 6 560
Twevan Cream Vol. 13 No. 6 561
Voriconazole 2% Ophthalmic Solution Vol. 13 No. 6 562
Wound Gel Vol. 13 No. 6 563
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes Vol. 13 No. 6 564
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel Vol. 13 No. 6 569
Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions Vol. 13 No. 6 572
PostScription: Compounding Seminar: International Pharmaceutical Federation Congress--Istanbul Vol. 13 No. 6 574